HCYT / H-CYTE Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

H-CYTE Inc
US ˙ OTC
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier44.446.528 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

H-CYTE Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HCYT / H-CYTE Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-01-17 Yurkowsky Michael 10.000 0,1450 10.000 0,1450 1.450 34 0.1900 450 31,03
2020-01-17 Yurkowsky Michael 1.900 0,1348 1.900 0,1348 256
2020-01-17 Yurkowsky Michael 5.000 0,1350 5.000 0,1350 675
2020-01-17 Yurkowsky Michael 8.100 0,1294 8.100 0,1294 1.048
2019-12-16 Yurkowsky Michael 7.500 0,1100 7.500 0,1100 825
2019-12-16 Yurkowsky Michael 27.500 0,1400 27.500 0,1400 3.850
2017-12-15 Thomas John C 6.000 0,7000 6.000 0,7000 4.200
2017-12-15 Mogford Jon 1.000 0,7000 1.000 0,7000 700
2017-08-21 GORLIN STEVE 50.000 1,2500 50.000 1,2500 62.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HCYT / H-CYTE Inc Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HCYT / H-CYTE Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-09-19 Haufe Scott 20.000 1,1800 20.000 1,1800 23.600 331 0.3200 -17.200 -72,88
2017-09-18 Haufe Scott 50.000 1,1900 50.000 1,1900 59.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HCYT / H-CYTE Inc Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-01-18 2024-01-16 4 WAGNER TODD R IVRN COMMON STOCK C - Conversion I 303.107 344.716
2024-01-18 2024-01-16 4 FARRIOR J REX III IVRN COMMON STOCK C - Conversion I 13.168 29.381
2022-03-23 2022-03-21 4 Lynch Frederick J (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS J - Other I 0,01 0,0140 8.321.785 117 8.321.785
2022-03-23 2022-03-21 4 Lynch Frederick J (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS X - Other I 0,01 -8.321.785 17.886.434
2022-03-23 2022-03-21 4 Lynch Frederick J (SEE FOOTNOTE) HCYT COMMON STOCK X - Other I 0,0140 8.321.785 117 8.321.785
2022-02-25 2022-02-23 4 FARRIOR J REX III (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS A - Award I 0,01 0,0140 693.477 10 693.477
2022-02-25 2022-02-23 4 FARRIOR J REX III (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS M - Exercise I 0,01 -693.477 6.794.586
2022-02-25 2022-02-23 4 FARRIOR J REX III (SEE FOOTNOTE) HCYT COMMON STOCK M - Exercise I 0,0140 693.477 10 16.211.588
2022-02-25 2022-02-23 4 WAGNER TODD R (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS A - Award I 0,01 0,0140 41.608.884 583 41.608.884
2022-02-25 2022-02-23 4 WAGNER TODD R (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS M - Exercise I 0,01 -41.608.884 224.259.729
2022-02-25 2022-02-23 4 WAGNER TODD R (SEE FOOTNOTE) HCYT COMMON STOCK M - Exercise I 0,0140 41.608.884 583 41.608.884
2021-07-01 2021-06-29 4 Yurkowsky Michael HCYT Common stock D - Sale to Issuer I 0,2000 -5.000 -1 3.258.750
2021-07-01 2021-06-29 4 Yurkowsky Michael HCYT Common stock D - Sale to Issuer I 0,1900 -5.000 -1 3.263.750
2021-07-01 2021-06-29 4 Yurkowsky Michael HCYT Common stock D - Sale to Issuer I 0,1600 -21.500 -3 3.268.750
2021-07-01 2021-06-29 4 Yurkowsky Michael HCYT Common stock D - Sale to Issuer I 0,1700 -38.000 -6 3.290.250
2021-04-29 2020-09-24 4 Horne William E HCYT STOCK PURCHASE WARRANTS J - Other I 0,01 1.869.667 1.869.667
2021-04-29 2020-09-24 4 Horne William E HCYT SERIES A PREFERRED STOCK J - Other I 0,0140 3.655.382 51 3.655.382
2021-04-14 2021-04-01 4/A Daniel Jeremy HCYT Stock Option (right to buy) A - Award D 0,07 5.000.000 5.000.000
2021-04-12 2021-04-01 4 Daniel Jeremy HCYT Stock Option (right to buy) A - Award D 0,07 5.000.000 5.000.000
2021-04-12 3 Daniel Jeremy HCYT Common Stock I 412.495
2021-04-08 2020-09-24 4 WAGNER TODD R (SEE FOOTNOTE) HCYT SERIES A PREFERRED STOCK J - Other I 0,0140 110.219.286 1.543 336.785.550
2021-04-08 2020-09-24 4 WAGNER TODD R (SEE FOOTNOTE) HCYT STOCK PURCHASE WARRANTS J - Other I 0,01 265.868.613 265.868.613
2021-04-08 2020-09-24 4 WAGNER TODD R (SEE FOOTNOTE) HCYT SERIES A PREFERRED STOCK J - Other I 0,0140 226.566.264 3.172 226.566.264
2021-04-08 3 FWHC BRIDGE, LLC HCYT No securities are beneficially owned. D 0
2021-04-05 2021-04-01 4 Yurkowsky Michael HCYT Stock Option (right to buy) A - Award D 0,07 3.500.000 3.500.000
2021-04-05 2021-04-01 4 Monteleone Raymond HCYT Stock Option (right to buy) A - Award D 0,07 3.000.000 3.000.000
2021-04-05 2021-04-01 4 Horne William E HCYT Stock Option (right to buy) A - Award D 0,07 2.000.000 2.000.000
2021-04-05 2021-04-01 4 Greif Robert Smith HCYT Stock Option (right to buy) A - Award D 0,07 34.000.000 34.000.000
2021-04-05 3 Monteleone Raymond HCYT Common Stock I 92.185
2021-03-15 2020-09-24 4 FARRIOR J REX III (SEE FOOTNOTE} HCYT SERIES A PREFERRED STOCK J - Other I 0,0140 7.142.857 100 14.630.920
2021-03-15 2020-09-24 4 FARRIOR J REX III (SEE FOOTNOTE} HCYT STOCK PURCHASE WARRANTS J - Other I 0,01 7.488.063 7.488.063
2021-03-15 2020-09-24 4 FARRIOR J REX III (SEE FOOTNOTE} HCYT SERIES A PREFERRED STOCK J - Other I 0,0140 7.488.063 105 7.488.063
2021-03-15 2020-07-23 4 FARRIOR J REX III (SEE FOOTNOTE} HCYT SERIES D PREFERRED STOCK C - Conversion I 0,41 15.518.111 0
2021-03-15 2020-07-23 4 FARRIOR J REX III (SEE FOOTNOTE} HCYT COMMON STOCK C - Conversion I 0,4082 15.518.111 6.334 15.518.111
2020-06-26 2020-06-23 4 Horne William E See footnotes HCYT Warrant A - Award I -4.368.278 4.368.278
2020-06-26 2020-06-23 4 Horne William E See Footnotes HCYT Common Stock A - Award I 0,3900 4.368.278 1.704 8.593.913
2020-01-21 2020-01-17 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1450 10.000 1 1.531.207
2020-01-21 2020-01-17 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1348 1.900 0 1.521.207
2020-01-21 2020-01-17 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1350 5.000 1 1.519.307
2020-01-21 2020-01-17 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1294 8.100 1 1.514.307
2019-12-20 3 Yurkowsky Michael HCYT Common Stock D 2.493.216
2019-12-20 3 Yurkowsky Michael HCYT Common Stock D 2.493.216
2019-12-20 3 Yurkowsky Michael HCYT Common Stock I 1.920.405
2019-12-20 3 Yurkowsky Michael HCYT Common Stock I 1.920.405
2019-12-20 3 Yurkowsky Michael HCYT Common Stock D 2.493.216
2019-12-20 3 Yurkowsky Michael HCYT Common Stock I 1.920.405
2019-12-20 2019-12-16 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1100 7.500 1 1.506.207
2019-12-20 2019-12-16 4 Yurkowsky Michael HCYT Common Stock P - Purchase D 0,1400 27.500 4 1.498.707
2019-09-18 3 Horne William E By RMS Shareholders, LLC HCYT Common Stock I 17.874.772
2019-09-18 3 Horne William E By RMS Shareholders, LLC HCYT Common Stock I 17.874.772
2019-09-18 3 Horne William E By RMS Shareholders, LLC HCYT Common Stock I 17.874.772
2019-05-31 3/A Horne William E By RMS Shareholder, LLC HCYT Common Stock I 8.901.948
2019-04-29 2019-01-08 4 Horne William E HCYT Options A - Award D 0,40 250.000 250.000
2019-04-29 2019-04-25 4 Horne William E HCYT Common Stock A - Award D 4.225.634 4.225.634
2019-04-29 3 Horne William B By RMS Shareholders, LLC MDVX Common Stock I 17.874.772
2019-04-29 3 Horne William B By RMS Shareholders, LLC MDVX Common Stock I 17.874.772
2019-04-29 3 Horne William B By RMS Shareholders, LLC MDVX Common Stock I 17.874.772
2019-04-29 2019-04-25 4 Horne William B MDVX Common Stock A - Award D 4.225.634 4.225.634
2018-01-12 2018-01-11 4 Crowne Jesse MDVX Common Stock A - Award D 0,5500 10.407 6 210.747
2018-01-05 2018-01-03 4 Crowne Jesse MDVX Common Stock A - Award D 0,5500 4.093 2 200.340
2018-01-02 2017-12-29 4 Betz Randal R MDVX Common Stock A - Award D 0,5210 350 0 181.027
2018-01-02 2017-12-29 4 Betz Randal R MDVX Common Stock A - Award D 0,5580 9.650 5 180.677
2017-12-20 2017-12-15 4/A Mogford Jon MDVX Common Stock P - Purchase D 0,7000 1.000 1 16.840
2017-12-20 2017-12-15 4/A Thomas John C MDVX Common Stock P - Purchase D 0,7000 6.000 4 115.960
2017-12-19 2017-12-15 4 Mogford Jon MDVX Common Stock P - Purchase D 0,7000 -1.000 -1 16.840
2017-12-19 2017-12-15 4 Thomas John C MDVX Common Stock P - Purchase D 0,7000 -6.000 -4 115.960
2017-11-01 2017-10-30 4 Thomas John C MDVX Common Stock A - Award D 1,1700 12.821 15 109.960
2017-11-01 2017-10-30 4 PAPASAN LARRY W MDVX Common Stock A - Award D 1,1700 12.821 15 228.136
2017-11-01 2017-10-30 4 Mogford Jon MDVX Common Stock A - Award D 1,1700 12.821 15 15.840
2017-11-01 2017-10-30 4 Betz Randal R MDVX Common Stock A - Award D 1,1700 12.821 15 164.837
2017-11-01 2017-10-30 4 Lawson James Ronald JR MDVX Common Stock A - Award D 1,1700 12.821 15 18.256
2017-11-01 2017-10-30 4 Haufe Scott MDVX Common Stock A - Award D 1,1700 12.821 15 1.031.782
2017-11-01 2017-10-30 4 Crowne Jesse MDVX Common Stock A - Award D 1,0800 31.240 34 200.340
2017-11-01 2017-10-30 4 Crowne Jesse MDVX Common Stock A - Award D 1,1700 2.137 3 169.100
2017-11-01 2017-10-30 4 GORLIN STEVE MDVX Common Stock A - Award D 1,1700 10.684 13 1.640.704
2017-11-01 2017-10-30 4 Hennies Clyde A. MDVX Common Stock A - Award D 1,1700 12.821 15 131.348
2017-11-01 2017-10-30 4 ANDREWS JAMES R M D MDVX Common Stock A - Award D 1,1700 12.821 15 131.348
2017-09-21 2017-09-19 4 Haufe Scott MDVX Common Stock S - Sale D 1,1800 -20.000 -24 1.018.961
2017-09-21 2017-09-18 4 Haufe Scott MDVX Common Stock S - Sale D 1,1900 -50.000 -60 1.038.961
2017-09-01 3 Crowne Jesse MDVX Common stock D 333.926
2017-09-01 3 Crowne Jesse MDVX Common stock D 333.926
2017-08-22 2017-08-21 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,2500 50.000 62 1.630.020
2017-08-16 2017-08-16 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9000 200.000 180 1.580.020
2017-07-18 2017-07-14 4 Betz Randal R MDVX Common Stock Purchase Warrant P - Purchase D 1,15 0,1250 5.495 1 5.495
2017-07-18 2017-07-14 4 Betz Randal R MDVX Common Stock P - Purchase D 0,9100 10.989 10 152.016
2017-06-29 2017-06-28 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,8800 2.000 2 1.380.020
2017-06-29 2017-06-28 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,8700 3.000 3 1.378.020
2017-06-20 2017-06-19 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,9000 20.000 18 662.172
2017-06-15 2017-06-14 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9700 5.000 5 1.375.020
2017-06-08 2017-06-07 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9800 5.000 5 1.370.020
2017-06-08 2017-06-07 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9600 5.000 5 1.365.020
2017-06-08 2017-06-07 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9500 15.000 14 1.360.020
2017-06-08 2017-06-07 4 GORLIN STEVE MDVX Common Stock P - Purchase D 0,9400 5.000 5 1.345.020
2017-06-07 2017-06-06 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,9400 5.000 5 642.172
2017-06-07 2017-06-06 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,9200 5.000 5 637.172
2017-06-07 2017-06-06 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,9100 5.000 5 632.172
2017-06-07 2017-06-06 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,9000 5.000 4 627.172
2017-06-07 2017-06-06 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 0,8900 5.000 4 622.172
2017-04-18 2017-04-18 4 Haufe Scott MDVX Common Stock P - Purchase D 1,2500 50.000 62 1.088.961
2017-03-30 2017-03-28 4/A Haufe Scott MDVX Common Stock P - Purchase D 1,2900 250.612 323 1.038.961
2017-03-30 2017-03-28 4 Haufe Scott MDVX Common Stock P - Purchase D 1,2900 250.612 323 1.038.961
2017-02-27 2017-02-03 4 Wright Jeffery Scott MDVX Options to Purchase Common Stock A - Award D 1,13 23.009 23.009
2017-02-27 2017-02-03 4 Kullmann Patrick C MDVX Options to Purchase Common Stock A - Award D 1,13 40.885 40.885
2017-02-27 2017-02-03 4 Sablowski Manfred MDVX Options to Purchase Common Stock A - Award D 1,13 26.549 26.549
2017-02-27 2017-02-03 4 Gorlin Jarrett S MDVX Options to Purchase Common Stock A - Award D 1,13 48.142 48.142
2017-02-27 2017-02-03 4 Moon Dennis Glenn MDVX Options to Purchase Common Stock A - Award D 1,13 35.575 35.575
2017-02-22 2017-02-17 4 GORLIN STEVE MDVX Warrants P - Purchase D 3,00 0,3500 19.179 7 79.179
2017-02-22 2017-02-17 4 GORLIN STEVE MDVX Warrants P - Purchase D 3,00 0,3600 60.000 22 60.000
2017-02-14 2017-02-09 4 Gorlin Jarrett S MDVX Warrant to purchase shares of Common Stock P - Purchase D 1,50 1,0400 33.654 35 95.968
2017-02-14 2017-02-09 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 1,0400 67.307 70 617.172
2017-02-14 2017-02-09 4 GORLIN STEVE MDVX Warrants P - Purchase D 1,50 1,0400 72.115 75 459.615
2017-02-14 2017-02-09 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,0400 144.230 150 1.340.020
2017-01-20 2017-01-12 4 PAPASAN LARRY W MDVX Common Stock A - Award D 1,3800 21.739 30 217.815
2017-01-17 2017-01-12 4 Thomas John C MDVX Common Stock A - Award D 1,3800 21.739 30 97.139
2017-01-17 2017-01-12 4 Betz Randal R MDVX Common Stock A - Award D 1,3800 21.739 30 141.027
2017-01-17 2017-01-12 4 Haufe Scott MDVX Common Stock A - Award D 1,3800 21.739 30 826.847
2017-01-17 2017-01-12 4 Hennies Clyde A. MDVX Common Stock A - Award D 1,3800 21.739 30 121.027
2017-01-17 2017-01-12 4 Lawson James Ronald JR MDVX Common Stock A - Award D 1,3800 5.435 8 5.435
2017-01-17 2017-01-12 4 Mogford Jon MDVX Common Stock A - Award D 1,3800 3.019 4 3.019
2017-01-17 2017-01-12 4 ANDREWS JAMES R M D MDVX Common Stock A - Award D 1,3800 21.739 30 121.027
2016-12-06 2016-12-01 4 GORLIN STEVE MDVX Warrants P - Purchase D 1,85 -112.500 387.500
2016-12-06 2016-12-01 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,7500 314.286 550 1.018.592
2016-12-06 2016-12-01 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,7500 -257.143 -450 704.360
2016-05-13 2016-04-19 4/A Gorlin Jarrett S MDVX Warrant to purchase shares of Common Stock P - Purchase D 1,30 21.514 62.314
2016-05-13 2016-04-19 4/A Gorlin Jarrett S MDVX Common Stock P - Purchase D 1,2550 43.028 54 560.065
2016-04-21 2016-04-19 4 Gorlin Jarrett S MDVX Warrant to purchase shares of Common Stock P - Purchase D 1,30 22.040 62.840
2016-04-21 2016-04-19 4 Gorlin Jarrett S MDVX Common Stock P - Purchase D 1,2250 44.081 54 561.118
2016-02-18 2016-02-16 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,8114 552.041 1.000 961.503
2016-01-08 2016-01-06 4 Gorlin Jarrett S MDVX Options to Purchase Common Stock A - Award D 0,95 40.800 40.800
2016-01-08 2016-01-06 4 Kullmann Patrick C MDVX Options to Purchase Common Stock A - Award D 0,95 34.650 69.650
2016-01-08 2016-01-06 4 Sablowski Manfred MDVX Options to Purchase Common Stock A - Award D 0,95 22.500 122.500
2016-01-08 2016-01-06 4 Wright Jeffery Scott MDVX Options to Purchase Common Stock A - Award D 0,95 19.500 69.500
2016-01-08 2016-01-06 4 Moon Dennis Glenn MDVX Options to Purchase Common Stock A - Award D 0,95 30.150 45.150
2015-12-22 2015-12-04 4 Betz Randal R MDVX Common Stock P - Purchase D 1,2500 20.000 25 119.288
2015-12-18 2015-12-10 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,0875 20.000 22 409.462
2015-12-18 2015-12-09 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,1459 20.000 23 389.462
2015-12-16 2015-12-15 4 Kullmann Patrick C MDVX Common Stock P - Purchase I 1,0900 4.500 5 247.019
2015-11-30 2015-11-24 4 GORLIN STEVE MDVX Common Stock P - Purchase D 1,4490 40.000 58 369.462
2015-11-30 2015-11-09 4 GORLIN STEVE MDVX Warrants P - Purchase D 2,20 1.100.000,0000 500.000 550.000.000 0
2015-11-30 2015-11-09 4 GORLIN STEVE MDVX Convertible Note P - Purchase D 2.000.000,0000 1 2.000 1
2015-11-25 2015-11-23 4 Hills Thomas Edward MDVX Common Stock P - Purchase D 1,3990 10.000 14 111.788
2015-11-25 2015-11-23 4 Haufe Scott MDVX Common Stock P - Purchase D 1,3500 5.000 7 805.108
2015-08-13 2015-08-11 4 Sablowski Manfred MDVX Option A - Award D 2,91 50.000 100.000
2015-06-24 2015-06-22 4 Haufe Scott MDVX Common Stock A - Award D 3,2500 25.000 81 800.108
2015-06-24 2015-06-22 4 Kullmann Patrick C MDVX Common Stock A - Award I 3,2500 3.000 10 242.519
2015-06-23 2015-06-22 4 Sablowski Manfred MDVX Common Stock A - Award D 3,2500 4.600 15 17.100
2015-06-03 2015-05-08 4 Kullmann Patrick C MDVX Option A - Award D 3,61 35.000 35.000
2015-06-02 2015-05-08 4 Moon Dennis Glenn MDVX Option A - Award D 3,61 15.000 15.000
2015-02-02 3 Hennies Clyde A. MDVX Common Stock D 198.576
2015-02-02 3 Hennies Clyde A. MDVX Common Stock D 198.576
2015-02-02 3 Hills Thomas Edward MDVX Common Stock D 198.576
2015-02-02 3 Hills Thomas Edward MDVX Common Stock D 198.576
2015-02-02 3 GORLIN STEVE Held by Reporting Person's Spouse MDVX Common Stock I 542.414
2015-02-02 3 GORLIN STEVE MDVX Common Stock D 709.828
2015-02-02 3 GORLIN STEVE Held by Reporting Person's Spouse MDVX Common Stock I 542.414
2015-02-02 3 GORLIN STEVE MDVX Common Stock D 709.828
2015-02-02 3 ANDREWS JAMES R M D MDVX Common Stock D 198.576
2015-02-02 3 ANDREWS JAMES R M D MDVX Common Stock D 198.576
2015-01-29 3 Gorlin Jarrett S MDVX Common Stock I 1.013.674
2015-01-29 3 Gorlin Jarrett S MDVX Common Stock I 1.013.674
2015-01-22 3 Moon Dennis Glenn MDVX Common Stock D 387.152
2015-01-22 3 Moon Dennis Glenn MDVX Common Stock D 387.152
2015-01-22 3 Farrahar Charles Duane MDVX Common Stock D 387.152
2015-01-22 3 Farrahar Charles Duane MDVX Common Stock D 387.152
2015-01-22 3 PAPASAN LARRY W MDVX Common Stock D 392.152
2015-01-22 3 PAPASAN LARRY W MDVX Common Stock D 392.152
2015-01-15 3 Haufe Scott MDVX Common Stock D 780.108
2015-01-15 3 Haufe Scott MDVX Common Stock I 1.545.216
2015-01-15 3 Haufe Scott MDVX Common Stock D 780.108
2015-01-15 3 Haufe Scott MDVX Common Stock I 1.545.216
2015-01-05 3 Betz Randal R MDVX Common Stock D 198.576
2015-01-05 3 Betz Randal R MDVX Common Stock D 198.576
2015-01-05 3 Kullmann Patrick C MDVX Common Stock D 290.364
2015-01-05 3 Kullmann Patrick C MDVX Common Stock D 290.364
2015-01-05 3 Kullmann Patrick C MDVX Common Stock I 290.364
2015-01-05 3 Kullmann Patrick C MDVX Common Stock I 290.364
2015-01-02 3 Thomas John C MDVX Common Stock D 150.800
2015-01-02 3 Thomas John C MDVX Common Stock D 150.800
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista